Biology Reference
In-Depth Information
Park IW, Koziel H, Hatch W, Li X, Du B, Groopman JE. 1999. CD4-dependent entry of human
immunode®ciency virus type-1 (HIV-1) env-pseudotypes into CCR5-, CCR3- and CXCR4-
expressing human alveolar macrophages is preferentially mediated by the CCR5 co-receptor.
Am J Respir Cell Mol Biol 20: 864±871.
Pearce TE, Nowakowski M, Eden E, Huang ZB, Steiner P, Shahabuddin M, Potash MJ, Volvsky
DJ. 1993. Uniform detection of HIV-1 in alveolar macrophages of pediatric but not adult AIDS
patients. J Leukoc Biol 53: 722±726.
Phelps DS, Rose RM. 1991. Increased recovery of surfactant protein A in AIDS-related pneumo-
nia. Am Rev Respir Dis 143: 1072±1075.
Reardon CC, Kim SJ, Wagner RP, Koziel H, Kornfeld H. 1996. Phagocytosis and growth inhibi-
tion of Cryptococcus neoformans by human alveolar macrophages: e¨ects of HIV-1 infection.
AIDS 10: 613±618.
Reed SG, Nathan CF, Pihl DL, Rodricks P, Shanebeck K, Conlon PJ, Grabstein KH. 1987. Re-
combinant granulocyte/macrophage colony stimulating-factor activates macrophages to inhibit
Typanasoma cruzi and release hydrogen peroxide: comparison with interferon gamma. J Exp
Med 166: 1734±1746.
Rich EA. 1998. HIV biology and infection of lung cells. In: Rosen MJ, Beck JM (eds). Human
Immunode®ciency Virus and the Lung. New York, Marcel Dekker, pp 87±125.
Rich EA, Chen IS, Zack JA, Leonard ML, O'Brien WA. 1992. Increased susceptibility of di¨er-
entiated mononuclear phagocytes to productive infection with human immunode®ciency virus-1
(HIV-1). J Clin Invest 89: 176±183.
Roth MD, Golub SH. 1993. Human pulmonary macrophages utilize prostaglandins and trans-
forming growth factor 1 to suppress lymphocyte activation. J Leukoc Biol 53: 366±371.
Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. 1986. Human T lymphotropic
virus type III infection of human alveolar macrophages. Blood 68: 281±284.
Shepherd VL. 1991. Cytokine receptors of the lung. Am J Resp Cell Mol Biol 5: 403±410.
Sibille Y, Reynolds HY. 1990. Macrophages and polymorphonuclear neutrophils in lung defense
and injury. Am Rev Respir Dis 141: 471±500.
Sierra-Madero J, Toossi Z, Hom DL, Finegan CK, Hoenig E, Rich EA. 1994. Relationship be-
tween load of virus in alveolar macrophages from human immunode®ciency virus type-1-
infected persons, production of cytokines, and clinical status. J Infect Dis 169: 18±27.
Skolnik PR, Mathys JM, Melanson S, Schi¨er-Alberts D, Koziel H. 2000. Decreased TNF-a/
sTNFRII expression by lung cells of HIV-infected asymptomatic persons. Am J Resp Crit Care
Med 161: A667.
Smith PD, Ohura K, Masur H, Lane HC, Fauci AS, Wahl SM. 1984. Monocyte function in
the acquired immune de®ciency syndrome. Defective chemotaxis. J Clin Invest 74: 2121±
2128.
Strickland DH, Kees UR, Holt PG. 1994. Suppression of T-cell activation by pulmonary alveolar
macrophages: dissociation of e¨ects on TCR, IL-2R expression and proliferation. Eur Respir J
7: 2124±2130.
Takemura R, Werb Z. 1984. Secretory products of macrophages and their physiological functions.
Am J Physiol 246: C1±C9.
Thomas ED, Rambergh RE, Sale GE, Sparkes RS, Golde DW. 1976. Direct evidence for bone
marrow origin of the alveolar macrophage in man. Science 192: 1016±1018.
Trentin L, Garbisa S, Zambello R, Agostini C, Caenazzo C, DiFrancesco C, Cipriani A, Franca-
villa E, Semenzato G. 1992. Spontaneous production of IL-6 by alveolar macrophages of HIV-1
seropositive patients. J Infect Dis 166: 731±737.
Twigg HL. 1997. Lung macrophages in human immunode®ciency viral infection. In: Lipscomb
MF, Russell SW (eds). Lung Macrophages and Dendritic Cells in Health and Disease. New
York, Marcel Dekker, pp 571±610.
Search WWH ::




Custom Search